Search Results
Found 6 results
510(k) Data Aggregation
(101 days)
The hip prostheses QUADRA-P and QUADRA-P collared are designed for cementless use in total or partial hip arthroplasty, for primary or revision surgery. The hip prosthesis QUADRA-P cemented is designed for cemented use in total or partial hip arthroplasty in primary or revision surgery. Hip replacement is indicated in the following cases: · Severely painful and/or disabled joint as a result of arthritis, rheumatoid polyarthritis or congenital hip dysplasia · Avascular necrosis of the femoral head · Acute traumatic fracture of the femoral head or neck · Failure of previous hip surgery: joint reconstruction, arthrodesis, partial hip arthroplasty, hip resurfacing replacement or total hip arthroplasty
The Quadra-P implant subject of this submission is a line extension to the currently cleared Ouadra-P implants (K181254 and K192827). The stem subject of this submission is a range extension of the Quadra-P Short Neck Standard stem cleared under K192827. The Quadra-P implant subject of this submission is the Quadra-P Short Neck STD stem size 00, a coated cementless stem, commercial reference 01.12.249. The Quadra-P implants are part of the Medacta Total Hip Prosthesis system. The Medacta Total Hip Prosthesis system consists of femoral stems, modular femoral heads, and acetabular components. Ouadra-P family includes cementless and cemented stems. Quadra-P, Quadra-P Short Neck, and Quadra-P Collared implants are cementless stems made with a titanium alloy substrate (Ti6Al7Nb) according to ISO 5832-11 Second Edition 2014-09-15: Implants for Surgery - Metallic Materials - Part 11: Wrought Titanium 6-Aluminium 7-Niobium Alloy. The femoral stems have a Eurocone (12/14 taper) and polished necks. Quadra-P, Quadra-P Short Neck, and Quadra-P Collared implants have an air plasma sprayed Titanium Y367 and Hydroxyapatite Osprovit (HA) dual layer coating on the proximal end of the shaft. The dual coating covers approximately 50% of the stem length. The distal part of the stem is coated with hydroxyapatite after sandblasting. Also included in Quadra-P family, are the Quadra-P Cemented stems manufactured from High Nitrogen Stainless Steel. The acetabular components consist of metal cups and liners made of ultra-high molecular weight polyethylene (UHMWPE) or Highcross highly crosslinked ultra-high molecular weight polyethylene (HXUHMWPE). Acetabular components include the Mpact DM (K143453). VersafitCup (K083116 and K092265), VersafitCup CC Trio (K103352), Mpact (K103721 and K132879), Mpact 3D Metal (K171966), and Medacta Bipolar Head (K091967). The Quadra-P implants can be combined with the CoCr Ball Heads (K072857 and K080885). Endo Head (K111145), MectaCer Biolox Option Heads (K131518), or MectaCer BIOLOX® Forte (K073337) or MectaCer BIOLOX® Delta Femoral Heads (K112115).
This document is a 510(k) Premarket Notification for a medical device (hip prosthesis). It does not contain information about an AI/ML-driven medical device or a study involving AI/ML performance. Therefore, it is impossible to extract the requested information regarding acceptance criteria and study details for an AI-driven device.
The document primarily focuses on demonstrating substantial equivalence of a new size of a Quadra-P hip prosthesis to previously cleared versions and other predicate devices. The "Performance Data" section details non-clinical mechanical studies (fatigue tests, range of motion, pull-off force, coating tests, pyrogenicity) conducted on the physical device, not on an algorithm's performance. It explicitly states: "No clinical studies were conducted."
To answer the user's request, I would need a document describing the validation of an AI/ML-driven medical device.
Ask a specific question about this device
(91 days)
The hip prosthesis SMS is designed for cementless use in total or partial hip arthroplasty, for primary or revision surgery. Hip replacement is indicated in the following cases:
· Severely painful and/or disabled joint as a result of arthritis, rheumatoid polyarthritis or congenital hip dysplasia
· Avascular necrosis of the femoral head
· Acute traumatic fracture of the femoral head or neck
· Failure of previous hip surgery: joint reconstruction, internal fixation, arthrodesis, partial hip arthroplasty, hip resurfacing replacement or total hip arthroplasty.
The SMS femoral stem is a cementless bone preserving short stem designed for proximal fixation in total or partial hip arthroplasty for primary or revision surgery.
The SMS implants are comprised of the following products:
- SMS Cementless Solid Standard Stem (available in 11 sizes from size 3 to 13); and ●
- . SMS Cementless Solid Lateralized Stem (available in 11 sizes - from size 3 to 13).
Both are available on the US market via the clearance - K181693.
Concerning the new sizes of the solid version: 1V2, 2V2, size 14, and size 15; both STD and LAT versions have been introduced as a product range extension to the stems currently marketed as the SMS product line (K181693).
The SMS implants are line extensions to Medacta's Total Hip Prosthesis - AMIStem-H, Quadra-S and Quadra-H Femoral Stems (K093944), AMIStem and Quadra - Line Extension (K121011), AMIStem-P, AMIStem-P Collared and AMIStem-H Proximal Coating Femoral Stems (K173794), Quadra-H and Quadra-R Femoral Stems (K082792), AMIStem-H Proximal Coating (K161635), MiniMAX (K170845), and SMS (K181693).
The SMS implants are part of the Medacta Total Hip Prosthesis system. The Medacta Total Hip Prosthesis system consists of femoral stems, modular femoral heads and acetabular components. The acetabular components consist of metal cups and liners made of ultra-high molecular weight polyethylene (UHMWPE) or Highcross highly crosslinked ultra-high molecular weight polyethylene (HXUHMWPE). Acetabular components include the Mpact DM (K143453), VersafitCup (K083116 and K092265), VersafitCup CC Trio (K103352), Mpact (K103721 and K132879), Mpact 3D Metal (K171966) and Medacta Bipolar Head (K091967).
The SMS stems can be combined with the CoCr ball heads (K072857, K080885 and K103721), Endo Head (K111145) or with the MectaCer BIOLOX® Forte (K073337), MectaCer BIOLOX® Delta Femoral Heads (K112115) or MectaCer BIOLOX® Option Heads (K131518).
This is a 510(k) premarket notification for the "SMS Cementless Stem" (K201673), a hip prosthesis. The document details the device, its intended use, and a comparison to predicate devices, along with performance data.
Here's an analysis of the provided text in relation to your request:
1. Table of Acceptance Criteria and Reported Device Performance
The document outlines various non-clinical performance tests conducted for the SMS Cementless Stem. However, it does not provide specific acceptance criteria values or the quantitative results of these tests in a table format. It only states that the testing was conducted "according to written protocols with acceptance criteria that were based on standards."
Here's what can be inferred for a table, but actual criteria values and results are missing in the document:
Test (Standard) | Acceptance Criteria (Not provided explicitly, generally "meet standard requirements") | Reported Device Performance (Not provided explicitly, implied "met criteria") |
---|---|---|
Range of Motion (EN ISO 21535:2009) | Based on standard EN ISO 21535:2009 | Conducted |
Fatigue Testing - Stemmed Femoral Components (ISO 7206-4:2010 + AME 1:2016) | Based on standard ISO 7206-4 | Conducted |
Fatigue Testing - Head and Neck Region of Stemmed Femoral Components (ISO 7206-6:2013) | Based on standard ISO 7206-6 | Conducted |
Pull-off Force Testing - Taper Connections (ASTM F2009-00 (Reapproved 2011)) | Based on standard ASTM F2009-00 | Conducted |
Coating Tests - Hydroxyapatite (ISO 13779-1:2008) | Based on standard ISO 13779-1 | Conducted |
Coating Tests - Tension Testing of Calcium Phosphate and Metal Coatings (ASTM F1147-99) | Based on standard ASTM F1147-99 | Conducted |
Pyrogenicity - Bacterial Endotoxin Test (European Pharmacopoeia §2.6.14 / USP chapter ) | Based on European Pharmacopoeia §2.6.14 / USP chapter | Conducted |
Pyrogenicity - Pyrogen Test (USP chapter ) | Based on USP chapter | Conducted |
2. Sample Size Used for the Test Set and Data Provenance
The document explicitly states: "No clinical studies were conducted." Therefore, there is no test set in the context of human clinical data or patient outcomes. The "performance data" refers to non-clinical mechanical and material tests. The sample sizes for these mechanical tests are not provided in this summary. Data provenance is not applicable here as no human data was used.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications
Not applicable as no clinical studies were conducted and no ground truth in the clinical sense was established. The "ground truth" for the non-clinical tests would be the specifications and requirements of the referenced ISO and ASTM standards.
4. Adjudication Method for the Test Set
Not applicable as no clinical studies were conducted which would require adjudication of expert opinions or outcomes.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, and its effect size
No MRMC study was mentioned or performed, as "No clinical studies were conducted." This device is a mechanical implant, not an AI or diagnostic tool that would typically undergo MRMC studies.
6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This device is a hip implant, not an algorithm or AI system.
7. The Type of Ground Truth Used
For the non-clinical performance and coating tests, the "ground truth" implicitly refers to the
requirements and specifications outlined in the referenced international standards (ISO and ASTM) and the European Pharmacopoeia/USP chapters. The device is expected to meet these pre-defined engineering and material standards. This is a form of engineering/material specification compliance as ground truth.
8. The Sample Size for the Training Set
Not applicable. This device is a mechanical implant, not an AI or machine learning model that requires a training set.
9. How the Ground Truth for the Training Set Was Established
Not applicable, as there is no training set for this type of medical device's approval.
Ask a specific question about this device
(30 days)
The hip prosthesis AMIStem-C is designed for cemented use in total or partial hip arthroplasty in primary or revision surgery. Hip replacement is indicated in the following cases:
• Severely painful and/or disabled joint as a result of arthritis, rheumatoid polyarthritis or congenital hip dysplasia
· Avascular necrosis of the femoral head
· Acute traumatic fracture of the femoral head or neck
· Failure of previous hip surgery: joint reconstruction, arthrodesis, partial hip arthroplasty, hip resurfacing replacement or total hip arthroplasty
AMIStem-C is a straight triple tapered cemented femoral stem of rectangular cross-section, for use in total or partial hip arthroplasty for primary or revision surgery. The material is High Nitrogen Stainless steel in accordance with ISO 5832-9. Its superficial feature is a mirror polishing on the neck and the body: the whole body is mirror polished in order to minimize the wear due to the occasional contact between neck and cup, particularly in case of double-mobility cups, and to optimize the load transfer from stem to cement avoiding the stress shielding. The AMIStem-C femoral stem size 00 is a line extension to the stems to the currently marketed Amistem-C product line.
This document is a 510(k) premarket notification for a medical device, specifically a femoral stem for hip replacement. It generally focuses on demonstrating substantial equivalence to a predicate device rather than presenting a standalone study with defined acceptance criteria and detailed performance metrics as one might find in an AI/ML device submission.
Therefore, many of the requested elements (e.g., sample sizes for training/test sets, ground truth establishment methods, expert qualifications, MRMC studies, effect sizes of AI assistance) are not applicable as this submission is for a physical orthopedic implant, not an AI/ML-based diagnostic or treatment device.
However, I can extract the relevant information regarding performance testing that was leveraged from the predicate device to support the substantial equivalence claim.
Here's a breakdown of the requested information based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
The document does not explicitly state numerical "acceptance criteria" and "reported device performance" in the format typically used for AI/ML device evaluations (e.g., sensitivity, specificity, AUC). Instead, it states that the performance testing from the predicate device was leveraged because the new size does not create a new worst-case scenario. The acceptance is implicitly that the device performs equivalently to the predicate and passes the specified ISO standards.
Acceptance Criteria (Implicit) | Reported (Leveraged) Device Performance |
---|---|
Pass neck fatigue testing per ISO 7206-4:2010 | The subject AMIStem-C size 00 standard femoral stem does not create a new worst case, hence it is assumed to pass neck fatigue testing per ISO 7206-4:2010 based on predicate device performance. The specific quantitative results are not provided in this summary. |
Pass shaft fatigue testing per ISO 7206-6:2013 | The subject AMIStem-C size 00 standard femoral stem does not create a new worst case, hence it is assumed to pass shaft fatigue testing per ISO 7206-6:2013 based on predicate device performance. The specific quantitative results are not provided in this summary. |
Demonstrate acceptable Range of Motion (ROM) | The subject AMIStem-C size 00 standard femoral stem does not create a new worst case, hence it is assumed to have acceptable Range of Motion (ROM) evaluation based on predicate device performance. The specific quantitative results are not provided in this summary. |
Demonstrate acceptable Bacterial Endotoxin levels (LAL test and USP ) | The subject AMIStem-C size 00 standard femoral stem does not create a new worst case, hence it is assumed to have acceptable Bacterial Endotoxin Testing (LAL test and USP ) based on predicate device performance. The specific quantitative results are not provided in this summary. |
Sterilization validated | The subject AMIStem-C size 00 standard femoral stem does not create a new worst case, hence it is assumed to have undergone sterilization validation based on predicate device performance. The specific quantitative results are not provided in this summary. |
Shelf-life validated | The subject AMIStem-C size 00 standard femoral stem does not create a new worst case, hence it is assumed to have undergone shelf-life testing based on predicate device performance. The specific quantitative results are not provided in this summary. |
Substantial equivalence to predicate device (K103189, Medacta Total Hip Prosthesis System AMIStem C & QUADRA C Short Neck) in terms of materials, surface finish, biocompatibility, device usage, sterility, shelf-life, and packaging, and biomechanical performance. | The AMIStem C size 00 standard femoral stem is considered as safe and effective and substantially equivalent to the predicate device. The subject device's smaller stem length and neck offset do not introduce a new worst case. |
2. Sample size used for the test set and the data provenance
These concepts (test set, data provenance, country of origin, retrospective/prospective) are mostly associated with clinical studies or AI/ML evaluations. For this submission, which relies on engineering performance testing of a physical implant and leveraging predicate data:
- Sample Size: Not explicitly stated for each test (e.g., how many stems were tested for fatigue). The "test set" here refers to the physical samples used for the engineering tests.
- Data Provenance: The data is from engineering performance testing based on predicate device data, conducted to international standards (ISO). The specific country of origin for the testing or whether it's retrospective/prospective in a clinical sense is not directly relevant or stated, as it's mechanical testing data leveraged from an already cleared device.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not Applicable. This is an orthopedic implant being cleared based on mechanical performance and substantial equivalence to a predicate, not an AI/ML diagnostic requiring expert interpretation for ground truth.
4. Adjudication method for the test set
Not Applicable. Adjudication methods (e.g., 2+1, 3+1) are used for expert consensus on ground truth in clinical or image-based studies. This submission relies on objective engineering measurements against ISO standards.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not Applicable. This is not an AI/ML device.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not Applicable. This is not an AI/ML device.
7. The type of ground truth used
The "ground truth" for this device's performance is objective compliance with international engineering standards (ISO 7206-4:2010, ISO 7206-6:2013) and established biocompatibility/sterility standards (LAL test, USP ). The performance of the new design (size 00) is considered equivalent if it does not create a "new worst case" compared to the predicate device that has already demonstrated compliance with these standards.
8. The sample size for the training set
Not Applicable. This is not an AI/ML device.
9. How the ground truth for the training set was established
Not Applicable. This is not an AI/ML device.
Ask a specific question about this device
(96 days)
The hip prostheses QUADRA-P and QUADRA-P collared are designed for cementless use in total or partial hip arthroplasty, for primary or revision surgery. The hip prosthesis QUADRA-P cemented is designed for cemented use in total or partial hip arthroplasty in primary or revision surgery. Hip replacement is indicated in the following cases:
· Severely painful and/or disabled joint as a result of arthrosis, traumatic arthritis, rheumatoid polyarthritis or congenital hip dysplasia
· Avascular necrosis of the femoral head
· Acute traumatic fracture of the femoral head or neck
· Failure of previous hip surgery: joint reconstruction, internal fixation, arthrodesis, partial hip arthroplasty, hip resurfacing replacement or total hip arthroplasty.
The Quadra-P implants are line extensions to the currently cleared Quadra-P implants (K181254).
The Quadra-P implants in this submission are comprised of the following products:
- Quadra-P STD (Stem size 00); .
- Quadra-P Short Neck (STD Stem sizes 0 10 and LAT Stem sizes 0 10); ●
- . Quadra-P Collared (STD Stem sizes 00 - 10 and LAT Stem sizes 0 - 10); and
- Quadra-P Cemented (STD Stem sizes 0 8 and LAT Stem sizes 0 8). ●
The Quadra-P implants are part of the Medacta Total Hip Prosthesis system. The Medacta Total Hip Prosthesis system consists of femoral stems, modular femoral heads, and acetabular components.
The Quadra-P, Quadra-P short neck, and Quadra-P Collared are cementless stems manufactured from Titanium-Niobium alloy with a Titanium plasma spray coating (MectaGrip) on the proximal area and HA coating on the shaft. The Quadra-P Cemented stems manufactured from high nitrogen stainless steel.
The acetabular components consist of metal cups and liners made of ultra-high molecular weight polyethylene (UHMWPE), or Highcross highly crosslinked ultra-high molecular weight polyethylene (HXUHMWPE). Acetabular components include the Mpact DM (K143453), VersafitCup (K083116 and K092265), VersafitCup CC Trio (K103352, K120521 and K122911), Mpact (K103721 and K132879), Mpact 3D Metal (K171966), and Medacta Bipolar Head (K091967).
The Quadra-P implants can be combined with the CoCr Ball Heads (K072857 and K080885), Endo Head (K111145), or MectaCer BIOLOX® Forte (K073337) or MectaCer BIOLOX® Delta Femoral Heads (K112115). or MectaCer Biolox Option Heads (K131518).
MectaCer Biolox Option Heads (K131518) cannot be combined with Quadra-P cemented stems, but only with the Quadra-P cementless stems.
The provided text is related to a 510(k) submission for a medical device (Quadra-P hip prosthesis) and does not contain information about software or AI-powered devices. Therefore, it does not include the type of acceptance criteria and study details you've requested regarding AI performance.
The document discusses the substantial equivalence of modifications to an existing hip prosthesis to predicate devices, focusing on mechanical testing and biocompatibility assessments. It explicitly states: "No clinical studies were conducted."
To clarify, the information you've requested (acceptance criteria, sample size for test/training set, expert qualifications, adjudication, MRMC study, standalone performance, ground truth type) is typically found in submissions for AI/ML-powered medical devices, specifically for evaluating their diagnostic or prognostic performance. This document concerns a physical implantable device.
Ask a specific question about this device
(108 days)
The hip prosthesis AMIStem-P and AMIStem-P collared are designed for cementless use in total or partial hip arthroplasty, for primary or revision surgery. The hip prosthesis AMIStem-C is designed for cemented use in total or partial hip arthroplasty in primary or revision surgery.
Hip replacement is indicated in the following cases:
· Severely painful and/or disabled joint as a result of arthritis, rheumatoid polyarthritis or congenital hip dysplasia
- · Avascular necrosis of the femoral head
- · Acute traumatic fracture of the femoral head or neck
· Failure of previous hip surgery: joint reconstruction, arthrodesis, partial hip arthroplasty, hip resurfacing replacement or total hip arthroplasty
The AMIStem-P Short Neck femoral stems are line extensions to the AMIStem-P femoral stems cleared under K173794.
The devices subject to this 510(k) are comprised of the following products:
- AMIStem-P Short Neck STD, Stem sizes 00 to 9, and ●
- AMIStem-P Short Neck LAT, Stem sizes 0 to 8.
The AMIStem-P Short Neck femoral stems are cementless stems manufactured from titaniumniobium alloy (Ti-6A1-7Nb alloy) and are coated with titanium and HA.
This document is a 510(k) summary for the AMIStem-P Short Neck femoral stems, which are a line extension of existing devices. Therefore, the information provided focuses on demonstrating substantial equivalence to a predicate device rather than presenting a de novo study with detailed acceptance criteria and performance data for an AI-powered device.
Based on the provided text, the device is not an AI/ML medical device. It is a hip prosthesis (femoral stem). The "performance data" section describes mechanical testing (range of motion, fatigue, pull-off force) and pyrogenicity testing, which are standard for orthopedic implants, not software.
Therefore, the requested information about acceptance criteria, study details, sample sizes, ground truth, expert involvement, and MRMC studies, which are relevant for AI/ML device studies, cannot be extracted from this document as it does not pertain to such a device.
The document states that "The data and information provided in K173794 support the conclusion that the AMIStem-P Short Neck femoral stems are substantially equivalent and conform to applicable standards and FDA guidance." This implies that the performance of the new device is considered acceptable because it is substantially equivalent to a previously cleared device that met its performance criteria.
Here's what can be extracted regarding performance from the document:
1. Table of Acceptance Criteria and Reported Device Performance:
Test | Acceptance Criteria (Implied by Predicate Equivalence) | Reported Device Performance |
---|---|---|
Mechanical Performance | Conforms to applicable standards for hip-joint replacement implants (e.g., EN ISO 21535, ISO 7206-4, ISO 7206-6, ASTM F2009-00) for range of motion, fatigue, and pull-off force. | Subject devices (AMIStem-P Short Neck) do not represent a new worst case compared to the predicate (AMIStem-P femoral stem, K173794). The data and information in K173794 are considered sufficient to support the substantial equivalence of the mechanical performance. |
Pyrogenicity (Bacterial Endotoxin Test - LAL Test) | Endotoxin limit of |
Ask a specific question about this device
(154 days)
The hip prosthesis SMS is designed for cementless use in total or partial hip arthroplasty, for primary or revision surgery. Hip replacement is indicated in the following cases:
· Severely painful and/or disabled joint as a result of arthritis, rheumatoid polyarthritis or congenital hip dysplasia
· Avascular necrosis of the femoral head
· Acute traumatic fracture of the femoral head or neck
· Failure of previous hip surgery: joint reconstruction, internal fixation, arthroplasty, hip resurfacing replacement or total hip arthroplasty.
The SMS femoral stem is a cementless bone preserving short stem designed for proximal fixation in total or partial hip arthroplasty for primary or revision surgery. The SMS implants subject of this submission are comprised of the following products:
- SMS Cementless Solid Standard Stem (available in 11 sizes); and ●
- SMS Cementless Solid Lateralized Stem (available in 11 sizes).
The SMS implants are line extensions to Medacta's Total Hip Prosthesis - AMIStem-H, Quadra-S and Quadra-H Femoral Stems (K093944), AMIStem and Quadra - Line Extension (K121011), AMIStem-P, AMIStem-P Collared and AMIStem-H Proximal Coating Femoral Stems (K173794), Quadra-H and Quadra-R Femoral Stems (K082792), AMIStem-H Proximal Coating (K161635), and MiniMAX (K170845).
The SMS implants are part of the Medacta Total Hip Prosthesis system. The Medacta Total Hip Prosthesis system consists of femoral stems, modular femoral heads and acetabular components. The acetabular components consist of metal cups and liners made of ultra-high molecular weight polyethylene (UHMWPE) or Highcross highly crosslinked ultra-high molecular weight polvethylene (HXUHMWPE).
Acetabular components include the Mpact DM (K143453), VersafitCup (K083116 and K092265), VersafitCup CC Trio (K103352), Mpact (K103721 and K132879), Mpact 3D Metal (K171966) and Medacta Bipolar Head (K091967).
The SMS stems can be combined with the CoCr ball heads (K072857, K080885 and K103721), Endo Head (K111145) or with the MectaCer BIOLOX® Forte (K073337), MectaCer BIOLOX® Delta Femoral Heads (K112115) or MectaCer BIOLOX® Option Heads (K131518).
This document describes the premarket notification (510(k)) for the SMS Femoral Stem, a cementless bone-preserving short stem designed for proximal fixation in total or partial hip arthroplasty.
Here's an analysis of the provided text in relation to acceptance criteria and supporting studies, though it's important to note that this is a medical device submission, not an AI/ML device submission, so the questions regarding human readers, training sets, etc., are not directly applicable here. The document focuses on mechanical performance and biocompatibility for a physical implant.
1. A table of acceptance criteria and the reported device performance
The document lists performance tests and the standards they adhere to, implying that meeting these standards constitutes the acceptance criteria. However, it does not explicitly state numerical acceptance criteria and does not present specific performance data values in a table format. It merely states that "Testing was conducted according to written protocols with acceptance criteria that were based on standards." and that the studies "demonstrated substantial equivalence."
Here's a generalized representation based on the provided information:
Acceptance Criterion (Implicit) | Reported Device Performance |
---|---|
Conformance to EN ISO 21535:2009 (Range of Motion) | Testing conducted, supporting substantial equivalence. |
Conformance to ISO 7206-4:2010 (Fatigue Testing - Stem) | Testing conducted, supporting substantial equivalence. |
Conformance to ISO 7206-6:2013 (Fatigue Testing - Head/Neck) | Testing conducted, supporting substantial equivalence. |
Conformance to ISO 7206-10:2003 (Static Fatigue - Modular Heads) | Testing conducted, supporting substantial equivalence. |
Conformance to ASTM F2009-00 (Axial Disassembly Force) | Testing conducted, supporting substantial equivalence. |
Conformance to ISO 13779-1:2008 (Coating - Hydroxyapatite) | Testing conducted, supporting substantial equivalence. |
Conformance to ASTM F1147-99 (Tension Testing - Coatings) | Testing conducted, supporting substantial equivalence. |
Conformance to European Pharmacopoeia §2.6.14/USP (BET) | Testing conducted (LAL test), supporting substantial equivalence. |
Conformance to USP (Pyrogen Test) | Testing conducted, supporting substantial equivalence. |
2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
The document lists various non-clinical mechanical and coating tests, which typically involve physical samples of the device components. It does not specify the sample sizes (number of stems tested for fatigue, etc.) for each test. The provenance of the data is implicit: it's generated from laboratory testing of the device components. There is no clinical data or patient-derived data mentioned.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
This question is not applicable to this type of medical device submission. Ground truth and expert adjudication are relevant for AI/ML diagnostic devices, not for physical implants that undergo mechanical and material testing. The "ground truth" for these tests are the established scientific principles and measurement techniques outlined in the specified ISO and ASTM standards.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
This question is not applicable for the same reasons as #3. Mechanical testing results are typically objectively measured and evaluated against a standard, not subject to expert adjudication in the same way as diagnostic interpretations.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
This question is not applicable as this is not an AI/ML device. No MRMC study was conducted.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
This question is not applicable as this is not an AI/ML device.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
For the non-clinical tests, the "ground truth" is defined by the specifications and acceptable ranges outlined in the referenced international (ISO) and American (ASTM) standards. For instance, a fatigue test determines if the device can withstand a certain number of cycles at a specific load without failure, as per the standard's requirements. Pyrogenicity is determined by established biological testing methods (LAL test, USP pyrogen test).
8. The sample size for the training set
This question is not applicable as this is not an AI/ML device. There is no concept of a "training set" for a physical implant undergoing mechanical and material characterization.
9. How the ground truth for the training set was established
This question is not applicable as this is not an AI/ML device.
Ask a specific question about this device
Page 1 of 1